Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
“Cancer type, time since diagnosis of cancer, the types of anticancer treatments received, and shared risk factors such as smoking can all influence the risk of stroke after cancer,”
I don’t smoke but I am a long-term multiple myeloma survivor, I have had two chemotherapy-induced blood clots (DVT) and I live with chemotherapy-induced cardiomyopathy and atrial fibrillation aka Afib.
Not to complain, but daily research continues to uncover one long-term side effect after another. Insult to injury, my standard-of-care, FDA approved safe and effective cancer therapy wasn’t safe and it certainly was not effective! Remission, relapse, remission, relapse and “nothing more we can do for you…”
I’m not an oncologist but according to the first study linked below, I have an increased risk of stroke. I don’t take any form of conventional blood thinners such as coumadin, eliquis, etc.
So what do I do to reduce my risk of stroke?
Fortunately, many of the evidence-based but non-toxic therapies that I do to reduce my risk of stroke I also do to remain in complete remission from my blood cancer.
To learn more about multiple myeloma stroke risk- click now
If you’d like to learn more about evidence-based but non-toxic therapies to reduce your risk of stroke, scroll down the page, post a question or a comment and I will reply to you ASAP.
“Patients with multiple myeloma are at risk of thromboembolism. However, studies investigating the relationship between multiple myeloma and ischemic stroke are limited. Therefore, we conducted a nationwide population-based study to investigate the risk of stroke among patients with multiple myeloma and the association between myeloma-related therapy and development of stroke…
This study consisted of 2,296 patients with multiple myeloma and 22,960 matched individuals, with a median age of 65 years (interquartile range 55-73). One hundred thirteen cerebrovascular events developed among 2,296 patients with multiple myeloma, with a follow-up of 4,119.2 person-years. The stroke incidence was 1.23 times higher in the multiple myeloma cohort than in the matched cohort (27.4 vs. 22.2 per 1,000 person-years), with an age-, sex-, and comorbidity-adjusted HR of 1.38 (95% confidence interval [CI] 1.14-1.67; P < 0.001). The multivariable Cox proportional hazard models showed bortezomib treatment as an independent risk factor determining the subsequent stroke in patients with multiple myeloma (adjusted HR 2.01; 95% CI 1.22-3.28; P = 0.006). This effect was not seen with steroids, thalidomide, or other chemotherapy agents.
Conclusion. Our study reveals an increased risk of stroke among patients with multiple myeloma compared with the matched cohort. Bortezomib treatment is associated with a higher risk of stroke in patients with multiple myeloma.”
“A new systematic review revealed that people living with certain cancers as well as those in remission face a significantly higher risk for stroke than people with no history of cancer.
Previous research has suggested such a link exists, but until now, the evidence has not been robust enough to elicit guidelines on stroke risk and prevention in cancer patients.
Given that historically, “cancer prognosis has been very bad, [a potential cancer-stroke link] frankly didn’t matter,” said Eric Yang, MD, a cardiologist and director of the Cardio-Oncology Program at the University of California, Los Angeles. He was not involved in the current study.
The meta-analysis was challenging to conduct, according to Turner, largely because of the heterogeneity of the studies and the fact that the relationship between stroke incidence and cancer “is not a simple one.”
“Cancer type, time since diagnosis of cancer, the types of anticancer treatments received, and shared risk factors such as smoking can all influence the risk of stroke after cancer,” Turner and colleagues write…
Although no guidelines exist for stroke prevention or risk management for cancer patients, clinicians should be mindful that cancer can increase stroke risk. “When they’re seeing patients, [clinicians should] see that as an opportunity to look for risk factors of stroke and cardiovascular diseases,” Turner said…
“Keeping patients’ stroke risk factors at bay might increase the chance they can continue their cancer treatment and improve their quality of life,” Yang said…
“Cancer and stroke may occur separately in a patient, or cancer may lead to stroke via hypercoagulability, non-bacterial thrombotic endocarditis, direct tumor compression of blood vessels, or from therapy3..
A total of 7,529,481 cancer patients were included in the analysis; of these, 80,513 (1.1%) died of a stroke.
The risk of stroke among cancer patients is two times that of the general population and rises with longer follow-up time…”
“Nutrition is far more important in stroke risk than most physcians suppose. Healthy lifestyle choices reduce the risk of stroke by ~80%, and of the factors that increase the risk of stroke, the worst is diet: only ~0.1% of Americans consume a healthy diet, and only 8.3% consume a somewhat healthy diet.
A Cretan Mediterranean diet, high in olive oil, whole grains, fruits, vegetables and legumes, and low in cholesterol and saturated fat, can reduce stroke by 40% or more in high-risk patients…
Metabolic B12 deficiency is common and usually missed. It has serious neurological consequences, including an increase in the risk of stroke. It now clear that B vitamins to lower homocysteine reduce the risk of stroke, but we should probably be using methylcobalamin instead of cyanocobalamin.
“Coffee, tea — or both? People who sip several daily cups of either or both beverages may be less likely to have a stroke than people who don’t drink either, new research reports.
The study relied on data from 365,000 people who described their typical coffee and tea consumption. The participants were ages 50 to 74 when they joined the study, from 2006 to 2010.
During a median follow-up period of 11.4 years, researchers found a 32% lower risk of stroke among people who said they drank two to three cups of coffee and two to three cups of tea daily compared with people who drank neither beverage. The findings were published Nov. 16, 2021, in PLOS Medicine.
“Together, the data suggest a potential intracellular pathway by which resveratrol can provide cell/organ resistance against neuropathological conditions…”
“Frequent sauna bathing is associated with a reduced risk of stroke, according to a new international study. In a 15-year follow-up study, people taking a sauna 4-7 times a week were 61% less likely to suffer a stroke than those taking a sauna once a week…